Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase

Intracerebral hemorrhage (ICH) is a critical disease, highly associated with mortality and morbidity. Several studies have demonstrated the beneficial effect of mesenchymal stem cells (MSCs) on ICH, mostly focused on their mid-to-long-term effect. Acute hematoma expansion is one of the most importan...

Full description

Saved in:
Bibliographic Details
Main Authors: Bo Young Choi, Ok Joon Kim, Sae-Hong Min, Jeong Hyun Jeong, Sang Won Suh, Tae Nyoung Chung
Format: Article
Language:English
Published: Wiley 2018-01-01
Series:Stem Cells International
Online Access:http://dx.doi.org/10.1155/2018/1658195
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832552349641474048
author Bo Young Choi
Ok Joon Kim
Sae-Hong Min
Jeong Hyun Jeong
Sang Won Suh
Tae Nyoung Chung
author_facet Bo Young Choi
Ok Joon Kim
Sae-Hong Min
Jeong Hyun Jeong
Sang Won Suh
Tae Nyoung Chung
author_sort Bo Young Choi
collection DOAJ
description Intracerebral hemorrhage (ICH) is a critical disease, highly associated with mortality and morbidity. Several studies have demonstrated the beneficial effect of mesenchymal stem cells (MSCs) on ICH, mostly focused on their mid-to-long-term effect. Acute hematoma expansion is one of the most important prognostic factors of ICH. We hypothesized that MSCs would decrease mortality and hematoma size in acute ICH, based on the findings of a few recent researches reporting their effect on blood-brain barrier and endothelial integrity. Rat ICH models were made using bacterial collagenase. One hour after ICH induction, the rats were randomly divided into MSC-treated and control groups. Mortality, hematoma volume, ventricular enlargement, brain edema, and degenerating neuron count were compared at 24 hours after ICH induction. Expression of tight junction proteins (ZO-1, occludin) and coagulation factor VII mRNA was also compared. Mortality rate (50% versus 8.3%), hematoma size, ventricular size, hemispheric enlargement, and degenerating neuron count were significantly lower in the MSC-treated group (p=0.034, 0.038, 0.001, 0.022, and <0.001, resp.), while the expression of ZO-1 and occludin was higher (p=0.007 and 0.012). Administration of MSCs may prevent hematoma expansion in the hyperacute stage of ICH and decrease acute mortality by enhancing the endothelial integrity of cerebral vasculature.
format Article
id doaj-art-3f011df376714325add9ec30f11e1273
institution Kabale University
issn 1687-966X
1687-9678
language English
publishDate 2018-01-01
publisher Wiley
record_format Article
series Stem Cells International
spelling doaj-art-3f011df376714325add9ec30f11e12732025-02-03T05:58:46ZengWileyStem Cells International1687-966X1687-96782018-01-01201810.1155/2018/16581951658195Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute PhaseBo Young Choi0Ok Joon Kim1Sae-Hong Min2Jeong Hyun Jeong3Sang Won Suh4Tae Nyoung Chung5Department of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon 24252, Republic of KoreaDepartment of Neurology, CHA University School of Medicine, 59 Yatap-Ro, Bundang-Gu, Seongnam 13496, Republic of KoreaDepartment of Emergency Medicine, CHA University School of Medicine, 59 Yatap-Ro, Bundang-Gu, Seongnam 13496, Republic of KoreaDepartment of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon 24252, Republic of KoreaDepartment of Physiology, College of Medicine, Hallym University, Hallymdaehak-gil, Chuncheon 24252, Republic of KoreaDepartment of Emergency Medicine, CHA University School of Medicine, 59 Yatap-Ro, Bundang-Gu, Seongnam 13496, Republic of KoreaIntracerebral hemorrhage (ICH) is a critical disease, highly associated with mortality and morbidity. Several studies have demonstrated the beneficial effect of mesenchymal stem cells (MSCs) on ICH, mostly focused on their mid-to-long-term effect. Acute hematoma expansion is one of the most important prognostic factors of ICH. We hypothesized that MSCs would decrease mortality and hematoma size in acute ICH, based on the findings of a few recent researches reporting their effect on blood-brain barrier and endothelial integrity. Rat ICH models were made using bacterial collagenase. One hour after ICH induction, the rats were randomly divided into MSC-treated and control groups. Mortality, hematoma volume, ventricular enlargement, brain edema, and degenerating neuron count were compared at 24 hours after ICH induction. Expression of tight junction proteins (ZO-1, occludin) and coagulation factor VII mRNA was also compared. Mortality rate (50% versus 8.3%), hematoma size, ventricular size, hemispheric enlargement, and degenerating neuron count were significantly lower in the MSC-treated group (p=0.034, 0.038, 0.001, 0.022, and <0.001, resp.), while the expression of ZO-1 and occludin was higher (p=0.007 and 0.012). Administration of MSCs may prevent hematoma expansion in the hyperacute stage of ICH and decrease acute mortality by enhancing the endothelial integrity of cerebral vasculature.http://dx.doi.org/10.1155/2018/1658195
spellingShingle Bo Young Choi
Ok Joon Kim
Sae-Hong Min
Jeong Hyun Jeong
Sang Won Suh
Tae Nyoung Chung
Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
Stem Cells International
title Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
title_full Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
title_fullStr Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
title_full_unstemmed Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
title_short Human Placenta-Derived Mesenchymal Stem Cells Reduce Mortality and Hematoma Size in a Rat Intracerebral Hemorrhage Model in an Acute Phase
title_sort human placenta derived mesenchymal stem cells reduce mortality and hematoma size in a rat intracerebral hemorrhage model in an acute phase
url http://dx.doi.org/10.1155/2018/1658195
work_keys_str_mv AT boyoungchoi humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase
AT okjoonkim humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase
AT saehongmin humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase
AT jeonghyunjeong humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase
AT sangwonsuh humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase
AT taenyoungchung humanplacentaderivedmesenchymalstemcellsreducemortalityandhematomasizeinaratintracerebralhemorrhagemodelinanacutephase